Page 21 - Collaborative Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Early in the COVID-19 pandemic, the RECOVERY trial showed that anti-inflammatory therapy with 6 mg daily dexamethasone improved survival in patients requiring oxygen supplementation.1 Additional anti-inflammatory therapy with either interleukin-6 (IL-6) inhibitors or the Janus kinase inhibitor baricitinib was later shown to provide further benefit to such patients.2,3 However, because IL-6 inhibitors and Janus kinase inhibitors might be less appropriate for some patients (eg, those who are pregnant or who have liver or kidney impairment) and are likely to be unavailable in some health-care sys...

In patients hospitalised for COVID-19 with clinical hypoxia who required either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared with usual care, which included low-dose corticosteroids. The RECOVERY trial continues to assess the effects of higher dose corticosteroids in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation.

Florida reported 68 local dengue cases in 2022, mostly from Miami-Dade County.

Researchers are also assessing if there are any benefits of a higher corticosteroid dose for patients on ventilators.

Vaccine makers say the vaccine can mass produced at a moderate cost, which could help ease the significant malaria burden in African countries.